<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre=": Infectious diseases : Viral Diseases: Influenza : Zoonoses: Avian" exact="influenza" post="A viruses : Veterinary Science : Veterinary Diseases :"/>
 <result pre="author and source are properly credited. Abstract The highly pathogenic" exact="avian influenza" post="(HPAI) H5N1 viruses, especially the laboratory-generated H5N1 mutants, have"/>
 <result pre="and source are properly credited. Abstract The highly pathogenic avian" exact="influenza" post="(HPAI) H5N1 viruses, especially the laboratory-generated H5N1 mutants, have"/>
 <result pre="or preparation of the manuscript. page-count: Introduction The highly pathogenic" exact="avian influenza" post="(HPAI) A/H5N1 is considered a significant threat for the"/>
 <result pre="preparation of the manuscript. page-count: Introduction The highly pathogenic avian" exact="influenza" post="(HPAI) A/H5N1 is considered a significant threat for the"/>
 <result pre="(HPAI) A/H5N1 is considered a significant threat for the next" exact="influenza" post="pandemic. The genetic variability of this virus makes it"/>
 <result pre="role in preventing the dire predictions noted above. Among all" exact="influenza" post="virus proteins, HA, a major antigen on the viral"/>
 <result pre="immunogenicity over that of monomeric HA in vaccinated mice against" exact="influenza" post="A virus (IAV) infection, and 2) a H5N1 virus-like"/>
 <result pre="cross-reactive neutralizing antibodies preferentially binding to the oligomeric form of" exact="influenza" post="virus HA in humans [13], [14]. Previously, we have"/>
 <result pre="of H5N1 induced neutralizing activity against divergent strains of H5N1" exact="influenza" post="virus [15], suggesting that the HA1 subunit of HA"/>
 <result pre="we have designed a highly effective and safe vaccine against" exact="severe acute respiratory syndrome" post="(SARS) coronavirus (SARS-CoV) using the critical neutralizing domain in"/>
 <result pre="a class I fusion glycoprotein similar to the HA of" exact="influenza" post="virus, and shown its efficacy against SARS virus infections"/>
 <result pre="is protective against challenge with homologous or drifted live H5" exact="influenza" post="virus [31]. A consensus-HA-based DNA vaccine is also seen"/>
 <result pre="vaccine is also seen to protect mice against divergent H5N1" exact="influenza" post="viruses [32]. In addition, a live attenuated modified vaccinia"/>
 <result pre="a live attenuated modified vaccinia Ankara (MVA) vector vaccine expressing" exact="influenza" post="H5N1 HA induces substantial cross-clade protective immunity in vaccinated"/>
 <result pre="animals [33]. A Vero cell-derived, whole virus clade 2 H5N1" exact="influenza" post="vaccine is now in phase I/II study for safety"/>
 <result pre="As a receptor binding and fusion protein, the HA of" exact="influenza" post="virus plays an important role in initiating viral infection."/>
 <result pre="the main region for the induction of neutralizing activity against" exact="influenza" post="virus infection [15], [33], [35] and can be used"/>
 <result pre="[33], [35] and can be used for development of subunit" exact="influenza" post="vaccine. Indeed, we previously demonstrated that a recombinant protein"/>
 <result pre="is essential to identify the CND for designing an effective" exact="influenza" post="vaccine containing the major neutralizing domain in HA1. We"/>
 <result pre="developed as a universal candidate vaccine particularly against H5N1. Native" exact="influenza" post="HA protein is polymerized as trimer [9]. It seems"/>
 <result pre="expressed HA proteins induced antibody responses against HAs of seasonal" exact="influenza" post="A viruses including H1N1 and H3N2 (data not shown),"/>
 <result pre="to the HA of H5N1. Our results further demonstrated that" exact="influenza" post="H5N1 HA-specific proteins with polymeric conformational structures may significantly"/>
 <result pre="may significantly enhance cross-protective immunity against divergent strains of H5N1" exact="influenza" post="virus infections [14], [40], [44]. In summary, we identified"/>
 <result pre="potential to be further developed as an effective and safe" exact="influenza" post="vaccine for preventing H5N1 infection and similar strategy can"/>
 <result pre="Blood Center (Permit Number: 322). All experiments related to the" exact="influenza" post="viruses were performed in approved biosafety level 3 (BSL-3)"/>
 <result pre="diluted mouse sera were incubated with 100 TCID50 of H5N1" exact="influenza" post="virus containing VN/1194 (clade 1) or SZ/406H (clade 2.3.4)"/>
 <result pre="HattaM, DasSC, OzawaM, et al. (2012) Experimental adaptation of an" exact="influenza" post="H5 HA confers respiratory droplet transmission to a reassortant"/>
 <result pre="LinsterM, ChutinimitkulS, de WitE, et al. (2012) Airborne transmission of" exact="influenza" post="A/H5N1 virus between ferrets. Science336: 1534â€&quot;1541.22723413 3JiangS, LiR, DuL,"/>
 <result pre="3JiangS, LiR, DuL, LiuS (2010) Roles of the hemagglutinin of" exact="influenza" post="A virus in viral entry and development of antiviral"/>
 <result pre="of monoclonal antibodies against hemagglutinin of a highly pathogenic H5N1" exact="influenza" post="virus using yeast surface display. Biochem Biophys Res Commun409:"/>
 <result pre="JongeneelenM, et al. (2009) Antibody recognition of a highly conserved" exact="influenza" post="virus epitope. Science324: 246â€&quot;251.19251591 6GarciaJM, PepinS, LagardeN, MaES, VogelFR,"/>
 <result pre="LagardeN, MaES, VogelFR, et al. (2009) Heterosubtype neutralizing responses to" exact="influenza" post="A (H5N1) viruses are mediated by antibodies to virus"/>
 <result pre="LiY, AoZ, et al. (2009) Evaluation of conserved and variable" exact="influenza" post="antigens for immunization against different isolates of H5N1 viruses."/>
 <result pre="antibody responses against all clades and subclades of highly pathogenic" exact="avian influenza" post="H5N1 viruses. J Virol86: 6970â€&quot;6978.22496212 9StevensJ, BlixtO, TumpeyTM, TaubenbergerJK,"/>
 <result pre="responses against all clades and subclades of highly pathogenic avian" exact="influenza" post="H5N1 viruses. J Virol86: 6970â€&quot;6978.22496212 9StevensJ, BlixtO, TumpeyTM, TaubenbergerJK,"/>
 <result pre="Structure and receptor specificity of the hemagglutinin from an H5N1" exact="influenza" post="virus. Science312: 404â€&quot;410.16543414 10KhuranaS, SuguitanALJr, RiveraY, SimmonsCP, LanzavecchiaA, et"/>
 <result pre="RiveraY, SimmonsCP, LanzavecchiaA, et al. (2009) Antigenic fingerprinting of H5N1" exact="avian influenza" post="using convalescent sera and monoclonal antibodies reveals potential vaccine"/>
 <result pre="SimmonsCP, LanzavecchiaA, et al. (2009) Antigenic fingerprinting of H5N1 avian" exact="influenza" post="using convalescent sera and monoclonal antibodies reveals potential vaccine"/>
 <result pre="receptor binding domain mutations on receptor binding and transmissibility of" exact="avian influenza" post="H5N1 viruses. Virology413: 139â€&quot;147.21397290 12YenHL, AldridgeJR, BoonAC, IlyushinaNA, SalomonR,"/>
 <result pre="binding domain mutations on receptor binding and transmissibility of avian" exact="influenza" post="H5N1 viruses. Virology413: 139â€&quot;147.21397290 12YenHL, AldridgeJR, BoonAC, IlyushinaNA, SalomonR,"/>
 <result pre="AldridgeJR, BoonAC, IlyushinaNA, SalomonR, et al. (2009) Changes in H5N1" exact="influenza" post="virus hemagglutinin receptor binding domain affect systemic spread. Proc"/>
 <result pre="neutralizing antibodies that preferentially bind to the oligomeric form of" exact="influenza" post="virus hemagglutinin in humans. J Virol85: 10945â€&quot;10954.21865396 14WeldonWC, WangBZ,"/>
 <result pre="SkountzouI, et al. (2010) Enhanced immunogenicity of stabilized trimeric soluble" exact="influenza" post="hemagglutinin. PLoS One5: e12466.20824188 15DuL, LeungVH, ZhangX, ZhouJ, ChenM,"/>
 <result pre="e16555.21304591 16HeY, LuH, SiddiquiP, ZhouY, JiangS (2005) Receptor-binding domain of" exact="severe acute respiratory syndrome" post="coronavirus spike protein contains multiple conformation-dependent epitopes that induce"/>
 <result pre="Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of" exact="severe acute respiratory syndrome" post="coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses"/>
 <result pre="and functional bases for broad-spectrum neutralization of avian and human" exact="influenza" post="A viruses. Nat Struct Mol Biol16: 265â€&quot;273.19234466 21WeisWI, BrungerAT,"/>
 <result pre="Biol16: 265â€&quot;273.19234466 21WeisWI, BrungerAT, SkehelJJ, WileyDC (1990) Refinement of the" exact="influenza" post="virus hemagglutinin by simulated annealing. J Mol Biol212: 737â€&quot;761.2329580"/>
 <result pre="concern. Nature482: 153â€&quot;154.22294204 26Le DucJW, FranzDR (2012) Genetically engineered transmissible" exact="influenza" post="A/H5N1: A call for laboratory safety and security. Biosecur"/>
 <result pre="CaldwellM, GildermanL, BerwaldB, et al. (2011) Dose-sparing H5N1 A/Indonesia/05/2005 pre-pandemic" exact="influenza" post="vaccine in adults and elderly adults: a phase III,"/>
 <result pre="et al. (2010) A single immunization with CoVaccine HT-adjuvanted H5N1" exact="influenza" post="virus vaccine induces protective cellular and humoral immune responses"/>
 <result pre="is protective against challenge with homologous or drifted live H5" exact="influenza" post="virus. Vaccine29: 8888â€&quot;8897.21963871 32ChenMW, ChengTJ, HuangY, JanJT, MaSH, et"/>
 <result pre="A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1" exact="influenza" post="viruses. Proc Natl Acad Sci U S A105: 13538â€&quot;13543.18765801"/>
 <result pre="et al. (2011) Vectors based on modified vaccinia Ankara expressing" exact="influenza" post="H5N1 hemagglutinin induce substantial cross-clade protective immunity. PLoS One6:"/>
 <result pre="of a Vero cell-derived, whole virus clade 2 H5N1 (A/Indonesia/05/2005)" exact="influenza" post="vaccine. Vaccine30: 329â€&quot;335.22080174 35LinSC, HuangMH, TsouPC, HuangLM, ChongP, et"/>
 <result pre="et al. (2011) Recombinant trimeric HA protein immunogenicity of H5N1" exact="avian influenza" post="viruses and their combined use with inactivated or adenovirus"/>
 <result pre="al. (2011) Recombinant trimeric HA protein immunogenicity of H5N1 avian" exact="influenza" post="viruses and their combined use with inactivated or adenovirus"/>
 <result pre="Adjuvant-free immunization with hemagglutinin-Fc fusion proteins as an approach to" exact="influenza" post="vaccines. J Virol85: 3010â€&quot;3014.21191017 38MeierS, GutheS, KiefhaberT, GrzesiekS (2004)"/>
 <result pre="neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1" exact="influenza" post="virus. J Virol82: 6200â€&quot;6208.18417563 41ZhangMY, WangY, MankowskiMK, PtakRG, DimitrovDS"/>
 <result pre="functional oligomers and generates strain-specific SRID potency antibodies for pandemic" exact="influenza" post="vaccines. Vaccine29: 5657â€&quot;5665.21704111 45QiZ, PanC, LuH, ShuiY, LiL, et"/>
 <result pre="a safe and convenient neutralization assay for rapid screening of" exact="influenza" post="HA-specific neutralizing monoclonal antibodies. Biochem Biophys Res Commun397: 580â€&quot;585.20617558"/>
 <result pre="LinY, et al. (2010) Induction of protection against divergent H5N1" exact="influenza" post="viruses using a recombinant fusion protein linking influenza M2e"/>
 <result pre="divergent H5N1 influenza viruses using a recombinant fusion protein linking" exact="influenza" post="M2e to Onchocerca volvulus activation associated protein-1 (ASP-1) adjuvant."/>
 <result pre="using a recombinant fusion protein linking influenza M2e to Onchocerca" exact="volvulus" post="activation associated protein-1 (ASP-1) adjuvant. Vaccine28: 7233â€&quot;7240.20732469"/>
</results>
